日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

肝细胞癌中FOXM1/BUB1轴介导的致癌信号传导机制研究

Wang, Shuping; Mao, Yudong; Zeng, Tingyu; Yong, Tao; An, Yu; Li, Jipin; Wang, Yuan; Yang, Xiaojun; Guan, Quanlin

Dysregulated expression of cell cycle regulators CDC20, PLK1, BUB1, CDC45, CDCA5 in pancreatic ductal adenocarcinoma

胰腺导管腺癌中细胞周期调节因子 CDC20、PLK1、BUB1、CDC45、CDCA5 的表达失调

Naeem, Maryam; Qadeer, Kainat; Jabeen, Ishrat; Ahmed, Ibrar; Murtaza, Iram; Farooq, Javeria; Sultan, Aneesa

Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma

BUB1B作为肝细胞癌精准医学生物标志物的转化评价

Sun, Chun-Yu; Yu, Xi; Deng, Lin-Qi; Han, Yu-Jia; He, Li-Jie; Yan, Hong-Yan

BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer.

BUB1 促进细胞干细胞样特性,并可作为肺癌的诊断生物标志物。

Liu Mulin, Zhu Siqi, Zheng Qin, Ding Dapeng, Li Shijun

Hypoxia Triggers ALYREF-Mediated m(5)C Methylation of KIF20A to Activate KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells.

缺氧触发 ALYREF 介导的 KIF20A m(5)C 甲基化,从而激活 KIF20A/BUB1,使宫颈癌细胞产生铁死亡抵抗力。

Gao Yan, Zou Ting

Exploring the mechanism and therapeutic potential of BUB1 in regulating esophageal cancer progression based on 5-FU target prediction

基于5-FU靶点预测,探索BUB1在调控食管癌进展中的机制和治疗潜力

Luo, Liangqin; Lin, ZhiWu; Xiong, Zitong; Zhu, Peiquan; Wang, Xinglan; Lu, Jiaan; Li, Ruixiang; Pu, Jiangtao; Song, Qi

Multi-omics analysis identifies BUB1B as a cell cycle-related driver of bladder cancer progression.

多组学分析表明,BUB1B 是膀胱癌进展的细胞周期相关驱动因素。

The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous corona

BUB1 和 BUBR1 旁系同源基因构成着丝粒纤维冠的支架。

Cmentowski, Verena; Musacchio, Andrea

Correction for Deng et al., The Arabidopsis BUB1/MAD3 family protein BMF3 requires BUB3.3 to recruit CDC20 to kinetochores in spindle assembly checkpoint signaling

对邓等人文章的更正:拟南芥BUB1/MAD3家族蛋白BMF3需要BUB3.3才能将CDC20募集到纺锤体组装检查点信号中的着丝粒

Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma

全基因组 CRISPR 筛选发现 BUB1 激酶是恶性胸膜间皮瘤中一个可药物靶向的脆弱位点

Ece Cakiroglu ,Sude Eris ,Ozden Oz ,Gökhan Karakülah ,Serif Senturk